132 related articles for article (PubMed ID: 37532113)
1. Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
Thakur K; Janjua D; Aggarwal N; Chhokar A; Yadav J; Tripathi T; Chaudhary A; Senrung A; Shrivastav A; Bharti AC
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166817. PubMed ID: 37532113
[TBL] [Abstract][Full Text] [Related]
2. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
3. Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
Islam S; Mazumder Indra D; Basu M; Roychowdhury A; Das P; Dasgupta H; Roy A; Alam N; Mondal RK; Roychoudhury S; Panda CK
Virus Res; 2018 Jan; 243():1-9. PubMed ID: 28988982
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract][Full Text] [Related]
5. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
6. Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.
Villanueva R; Morales-Peza N; Castelán-Sánchez I; García-Villa E; Tapia R; Cid-Arregui A; García-Carrancá A; López-Bayghen E; Gariglio P
BMC Cancer; 2006 Aug; 6():218. PubMed ID: 16945153
[TBL] [Abstract][Full Text] [Related]
7. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
8. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S; Ishii Y; Takeuchi T; Kukimoto I
J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
[TBL] [Abstract][Full Text] [Related]
9. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
10. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
12. Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.
Thakur K; Janjua D; Shishodia G; Chhokar A; Aggarwal N; Yadav J; Tripathi T; Chaudhary A; Senrung A; Bharti AC
Med Oncol; 2022 Oct; 39(12):255. PubMed ID: 36224441
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC
Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777
[TBL] [Abstract][Full Text] [Related]
14. Deregulated TNF-Alpha Levels Along with HPV Genotype 16 Infection Are Associated with Pathogenesis of Cervical Neoplasia in Northeast Indian Patients.
Das CR; Tiwari D; Dongre A; Khan MA; Husain SA; Sarma A; Bose S; Bose PD
Viral Immunol; 2018 May; 31(4):282-291. PubMed ID: 29608425
[TBL] [Abstract][Full Text] [Related]
15. MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2.
Sinha A; Ghosh A; Ghosh A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Sengupta S
Clin Epigenetics; 2024 Mar; 16(1):40. PubMed ID: 38461243
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.
Rasheed K; Sveinbjørnsson B; Moens U
Virol J; 2021 Jul; 18(1):139. PubMed ID: 34217322
[TBL] [Abstract][Full Text] [Related]
17. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
Shukla S; Mahata S; Shishodia G; Pandey A; Tyagi A; Vishnoi K; Basir SF; Das BC; Bharti AC
PLoS One; 2013; 8(7):e67849. PubMed ID: 23874455
[TBL] [Abstract][Full Text] [Related]
18. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
